Posts Tagged ‘drug regulation’
If science-based medicine reflects the application of the best evidence, then we should expect practices to change when new data emerges. In the long run that’s generally true, and the progressive gains we’ve seen in the management of disease reflect this. But in the short run, change can be maddeningly slow, and there are many […]
Filed under: articles | 1 Comment
Tags: cardiovascular disease, drug regulation, nsaids, topical nsaids
All the best effort to practice science-based medicine are for naught when the optimal treatment is unavailable. And that’s increasingly the case – even for life-threatening illnesses. Shortages of prescription drugs, including cancer drugs, seem more frequent and more significant than at any time in the past. Just recently manufacturing deficiencies at a large U.S.-based […]
Filed under: articles | 1 Comment
Tags: drug regulation, drug shortages, fda, health canada
Online discussions on the merits of alternative medicine can get quite heated. And its proponents, given enough time, will inevitably cite the same drug as “evidence” of the failings of science. Call it Gavura’s Law, with apologies to Mike Godwin: As an online discussion on the effectiveness of alternative medicine grows longer, the probability that […]
Filed under: articles | 2 Comments
Tags: drug regulation, DSHEA, homeopathy, natural health products directorate, natural health products regulations, nhpd, thalidomide
Cross-posted from Science-Based Medicine. Imagine you’re an FDA reviewer looking at a new drug application. Drug A relieves a symptom, but doesn’t cure any disease. It doesn’t conflict with other medications. It’s considered safe in pregnant and breastfeeding women. At normal doses, there are virtually no side effects. There’s one unfortunate problem: If you take […]
Filed under: articles | Closed
Tags: drug regulation, otc
